This article originally posted 06 February, 2007 and appeared in Issue 350
Test Your Knowledge Issue 350
What statement is false regarding Pramlinitide:
Advertisement
1. Pramlintide, administered subcutaneously, has been shown to have a bioavailability of approximately 38-40%.
2. The time to achieve maximum concentration is 20 minutes, with the effect lasting up to 6 hours after drug administration.
3. Approximately 40% of the administered dose is found unbound in the plasma.
4. Pramlintide does not accumulate with administration of repeated doses.
5. Its elimination half-life is approximately 20-45 minutes.
6. Deslys pramlintide is the primary, active metabolite of the drug.
7. Unlike insulin, which is metabolized approximately 50% in the liver, pramlintide is metabolized and eliminated predominantly by the kidneys.
8. Since pramlintide possesses a wide therapeutic index, dosage adjustments are not required regardless of meal size or in the presence of mild-to-moderate renal insufficiency.
DISCLAIMER: The content of this Website is independent of the views of our advertisers and sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.
Copyright @ 1999-2012 Diabetes In Control, Inc.. All rights reserved.
Entries (RSS News)
